European Real-World Registry for Use of the Ion Endoluminal System (NCT06923774) | Clinical Trial Compass
RecruitingNot Applicable
European Real-World Registry for Use of the Ion Endoluminal System
France, Germany, Switzerland1,200 participantsStarted 2025-09-09
Plain-language summary
The objective of this study is to collect collect real-world data for the Ion endoluminal system.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient is aged 18 years or older at time of consent.
* Patient is planned to undergo a lung lesion biopsy(s) and/or localization procedure(s) utilizing the Ion endoluminal system.
* Patient is willing and able to give written informed consent for clinical study participation.
Exclusion Criteria:
* Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results.
* Female patient that is pregnant or breast feeding as determined by standard site practices.
* Patient is legally incapacitated or in a legal/court ordered institution or is part of a known vulnerable population, including but not limited to dependency on the sponsor, hospital or study doctor.
* Patient is not willing to comply with post-procedure study participation requirements.
* Investigator, in their professional opinion, has decided that it is in the patient's best interest to not participate in the clinical study.
What they're measuring
1
Diagnostic Yield
Timeframe: Intra-procedure through 24 month post-procedure